137 related articles for article (PubMed ID: 31841172)
1. Long noncoding RNA MIRG induces osteoclastogenesis and bone resorption in osteoporosis through negative regulation of miR-1897.
Ling L; Hu HL; Liu KY; Ram YI; Gao JL; Cao YM
Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10195-10203. PubMed ID: 31841172
[TBL] [Abstract][Full Text] [Related]
2. miR-218 is involved in the negative regulation of osteoclastogenesis and bone resorption by partial suppression of p38MAPK-c-Fos-NFATc1 signaling: Potential role for osteopenic diseases.
Qu B; Xia X; Yan M; Gong K; Deng S; Huang G; Ma Z; Pan X
Exp Cell Res; 2015 Oct; 338(1):89-96. PubMed ID: 26216483
[TBL] [Abstract][Full Text] [Related]
3. LncRNA AK077216 promotes RANKL-induced osteoclastogenesis and bone resorption via NFATc1 by inhibition of NIP45.
Liu C; Cao Z; Bai Y; Dou C; Gong X; Liang M; Dong R; Quan H; Li J; Dai J; Kang F; Zhao C; Dong S
J Cell Physiol; 2019 Feb; 234(2):1606-1617. PubMed ID: 30132869
[TBL] [Abstract][Full Text] [Related]
4. CircRNA_009934 induces osteoclast bone resorption via silencing miR-5107.
Miao F; Yin BH; Zhang X; Xue DD; Ma C
Eur Rev Med Pharmacol Sci; 2020 Jul; 24(14):7580-7588. PubMed ID: 32744684
[TBL] [Abstract][Full Text] [Related]
5. Osteoblasts-Derived Exosomal lncRNA-MALAT1 Promotes Osteoclastogenesis by Targeting the miR-124/NFATc1 Signaling Axis in Bone Marrow-Derived Macrophages.
Zhang C; Pan L; Zhang H; Ke T; Yang Y; Zhang L; Chen L; Tan J
Int J Nanomedicine; 2023; 18():781-795. PubMed ID: 36814857
[TBL] [Abstract][Full Text] [Related]
6. LncRNA Bmncr alleviates the progression of osteoporosis by inhibiting RANML-induced osteoclast differentiation.
Chen RS; Zhang XB; Zhu XT; Wang CS
Eur Rev Med Pharmacol Sci; 2019 Nov; 23(21):9199-9206. PubMed ID: 31773670
[TBL] [Abstract][Full Text] [Related]
7. EPC-derived exosomes promote osteoclastogenesis through LncRNA-MALAT1.
Cui Y; Fu S; Sun D; Xing J; Hou T; Wu X
J Cell Mol Med; 2019 Jun; 23(6):3843-3854. PubMed ID: 31025509
[TBL] [Abstract][Full Text] [Related]
8. 25-hydroxycholesterol promotes RANKL-induced osteoclastogenesis through coordinating NFATc1 and Sp1 complex in the transcription of miR-139-5p.
Zhang L; Lv Y; Xian G; Lin Y
Biochem Biophys Res Commun; 2017 Apr; 485(4):736-741. PubMed ID: 28257846
[TBL] [Abstract][Full Text] [Related]
9. RBP-J-Regulated miR-182 Promotes TNF-α-Induced Osteoclastogenesis.
Miller CH; Smith SM; Elguindy M; Zhang T; Xiang JZ; Hu X; Ivashkiv LB; Zhao B
J Immunol; 2016 Jun; 196(12):4977-86. PubMed ID: 27183593
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of RANKL-induced osteoclastogenesis by (-)-DHMEQ, a novel NF-kappaB inhibitor, through downregulation of NFATc1.
Takatsuna H; Asagiri M; Kubota T; Oka K; Osada T; Sugiyama C; Saito H; Aoki K; Ohya K; Takayanagi H; Umezawa K
J Bone Miner Res; 2005 Apr; 20(4):653-62. PubMed ID: 15765185
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-124 regulates osteoclast differentiation.
Lee Y; Kim HJ; Park CK; Kim YG; Lee HJ; Kim JY; Kim HH
Bone; 2013 Oct; 56(2):383-9. PubMed ID: 23867221
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of osteoclastogenesis and inflammatory bone resorption by targeting BET proteins and epigenetic regulation.
Park-Min KH; Lim E; Lee MJ; Park SH; Giannopoulou E; Yarilina A; van der Meulen M; Zhao B; Smithers N; Witherington J; Lee K; Tak PP; Prinjha RK; Ivashkiv LB
Nat Commun; 2014 Nov; 5():5418. PubMed ID: 25391636
[TBL] [Abstract][Full Text] [Related]
13. LncRNA MALAT1 sponges miR-204 to promote osteoblast differentiation of human aortic valve interstitial cells through up-regulating Smad4.
Xiao X; Zhou T; Guo S; Guo C; Zhang Q; Dong N; Wang Y
Int J Cardiol; 2017 Sep; 243():404-412. PubMed ID: 28522163
[TBL] [Abstract][Full Text] [Related]
14. Microtubule actin crosslinking factor 1 (MACF1) knockdown inhibits RANKL-induced osteoclastogenesis via Akt/GSK3β/NFATc1 signalling pathway.
Lin X; Xiao Y; Chen Z; Ma J; Qiu W; Zhang K; Xu F; Dang K; Qian A
Mol Cell Endocrinol; 2019 Aug; 494():110494. PubMed ID: 31260729
[TBL] [Abstract][Full Text] [Related]
15. Stauntonia hexaphylla (Lardizabalaceae) leaf methanol extract inhibits osteoclastogenesis and bone resorption activity via proteasome-mediated degradation of c-Fos protein and suppression of NFATc1 expression.
Cheon YH; Baek JM; Park SH; Ahn SJ; Lee MS; Oh J; Kim JY
BMC Complement Altern Med; 2015 Aug; 15():280. PubMed ID: 26271279
[TBL] [Abstract][Full Text] [Related]
16. Knockdown of TRPV4 suppresses osteoclast differentiation and osteoporosis by inhibiting autophagy through Ca
Cao B; Dai X; Wang W
J Cell Physiol; 2019 May; 234(5):6831-6841. PubMed ID: 30387123
[TBL] [Abstract][Full Text] [Related]
17. Trapidil, a platelet-derived growth factor antagonist, inhibits osteoclastogenesis by down-regulating NFATc1 and suppresses bone loss in mice.
Kim SD; Kim HN; Lee JH; Jin WJ; Hwang SJ; Kim HH; Ha H; Lee ZH
Biochem Pharmacol; 2013 Sep; 86(6):782-90. PubMed ID: 23928189
[TBL] [Abstract][Full Text] [Related]
18. Ganomycin I from Ganoderma lucidum attenuates RANKL-mediated osteoclastogenesis by inhibiting MAPKs and NFATc1.
Tran PT; Dat NT; Dang NH; Van Cuong P; Lee S; Hwangbo C; Van Minh C; Lee JH
Phytomedicine; 2019 Mar; 55():1-8. PubMed ID: 30668419
[TBL] [Abstract][Full Text] [Related]
19. Sappanone A inhibits RANKL-induced osteoclastogenesis in BMMs and prevents inflammation-mediated bone loss.
Choo YY; Tran PT; Min BS; Kim O; Nguyen HD; Kwon SH; Lee JH
Int Immunopharmacol; 2017 Nov; 52():230-237. PubMed ID: 28946117
[TBL] [Abstract][Full Text] [Related]
20. Hsa_circRNA_33287 promotes the osteogenic differentiation of maxillary sinus membrane stem cells via miR-214-3p/Runx3.
Peng W; Zhu S; Chen J; Wang J; Rong Q; Chen S
Biomed Pharmacother; 2019 Jan; 109():1709-1717. PubMed ID: 30551425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
